Biology / Biotechnology Technology Offers

Arkadiusz Rudawski, PhD posted this:
Technology Broker at Center for Technology Transfer, Cracow University of Technology

Synthesis of bioactive compounds We offer developed methods for the synthesis of known active substances by reaction in the presence of ultrasound and other eco-friendly methods. We also offer synthesis on request or a ready library of bioactive compounds with anti-cancer effect.

Synthesis of bioactive compounds

Arkadiusz Rudawski, PhD posted this:
Technology Broker at Center for Technology Transfer, Cracow University of Technology

Bioactive haemostatic agents with advanced biological properties The technology comprises the obtainment of physically crosslinked aerogel with a unique chemical structure, which is responsible for the exceptional sorption capacity and antioxidant properties leading to scavenging of reactive radicals, especially oxygen (ROSS). Biomaterials are obtained from resources of fungal and plant origin. The use of biocompatible substances eliminates the use of toxic reagents, so the method of preparation is in line with the limitations of Green Chemistry.

Arkadiusz Rudawski, PhD posted this:
Technology Broker at Center for Technology Transfer, Cracow University of Technology

A modern form of formulation on burn wound healing, containing bioactive lavender oil (Lavandula angustifolia)The subject of the invention will be a nanoformulation containing as a therapeutic ingredient bioactive lavender oil (Lavandula angustifolia).

Covid-19 Innovation Challenges by Innoget posted this:

COVID-19 Rapid Diagnostic Kit Designing and developing vaccines, cures and diagnostic kits can be considered as the first priority for every country which is in the first line of fighting against coronavirus. Now there is only PCR test and IgG/IgM test for COVID-19 assessment. One of the most important problems of this diagnostic test is the time needed by the device to detect infected persons. This problem makes big companies in the field of pharmaceutical and medical devices manufacturing to design and develop rapid test kits. Our research team found that there are some specific proteins on the viral membrane which can make some reagents undergo a specific chemical reaction. Every reaction has a specific product related to substrates, so by detection of products with indicator reagents we are able to identify the virus in saliva. Indicator reagents usually change the reaction mixture color so by color change we can approve that the person is infected by COVID-19.

COVID-19 Rapid Diagnostic Kit

Covid-19 Innovation Challenges by Innoget posted this:

Expertise in molecular biology either experimentally or computationally The Institut de Biotecnologia i de Biomedicina (IBB) was created in 1970 as a research institute of the Universitat Autònoma de Barcelona (UAB) to promote fundamental biological research. In the year 2000, the focus of research evolved towards the Biotechnology and Biomedicine fields, with the aim of advancing scientific findings into translational results. At present, the Institute hosts 18 research groups organised into 3 programmes and working in 7 areas of expertise: • Bioinformatics • Cellular Biology • Structural Biology • Genomics • Immunology • Microbiology • Proteomics. This multidisciplinary character, one of the most relevant characteristics of the IBB, allows for a broad approach to biological problems, both basic and applied. The IBB is also highly engaged in academic training at the undergraduate and postgraduate levels.

Expertise in molecular biology either experimentally or computationally

IBB-UAB posted this:

Expertise in molecular biology either experimentally or computationally The Institut de Biotecnologia i de Biomedicina (IBB) was created in 1970 as a research institute of the Universitat Autònoma de Barcelona (UAB) to promote fundamental biological research. In the year 2000, the focus of research evolved towards the Biotechnology and Biomedicine fields, with the aim of advancing scientific findings into translational results. At present, the Institute hosts 18 research groups organised into 3 programmes and working in 7 areas of expertise: • Bioinformatics • Cellular Biology • Structural Biology • Genomics • Immunology • Microbiology • Proteomics. This multidisciplinary character, one of the most relevant characteristics of the IBB, allows for a broad approach to biological problems, both basic and applied. The IBB is also highly engaged in academic training at the undergraduate and postgraduate levels.

Expertise in molecular biology either experimentally or computationally

Covid-19 Innovation Challenges by Innoget posted this:

Inhibitors of Viral Infectivity: Amphipathic Nucleoside Derivatives as Fusion Inhibitors A series of small pharmacological molecules have been discovered to be potent and non-cytotoxic inhibitors of viral fusion. The inhibitors act on the non-virally encoded lipids in the virion envelope. These molecules are rigid amphipathic compounds of inverted cone shape which locate to the outer leaflets of virion envelopes, creating a physical barrier to viral envelope and cell membrane fusion. These amphipathic nucleoside derivatives can serve as potential antiviral or therapeutic agents against herpes, HIV, influenza, hepatitis B & C, poxvirus and other DNA or RNA enveloped viruses. They can potentially be used as prophylactic ingredients in creams, lotions, gels and as antiviral disinfectants.

Inhibitors of Viral Infectivity: Amphipathic Nucleoside Derivatives as Fusion Inhibitors

Centre Technology Transfer CITTRU posted this:

A NEW DRUG FOR THE PREVENTION AND TREATMENT OF FELINE HERPESVIRUS TYPE 1 (FHV-1) AND FELINE CALICIVIRUS (FCV) INFECTIONS The subject of the proposed offer is a new innovation of the Jagiellonian University - a new potential drug - poly(sodium 4-styrenesulfonates), (PSSNa), which can be used for treatment of FHV-1 and FCV infections.

A NEW DRUG FOR THE PREVENTION AND TREATMENT OF FELINE HERPESVIRUS TYPE 1 (FHV-1) AND FELINE CALICIVIRUS (FCV) INFECTIONS

Ivan Rodriguez Rosello posted this:
Licensing Manager at Universidad de Alicante

Novel bioadhesive for wound closure in animals or humans The Adhesion and Adhesives Laboratory research group has developed a new biomaterial for use as adhesive or tissue sealant applicable to both animals and humans. This invention solves the disadvantages of the adhesives known so far presenting optimal properties such as biocompatibility with living tissues, high adhesive capacity, adaptable to the tissue of the wound being bond, absence of toxicity and tissue regeneration properties. The group is looking for companies interested in acquiring this technology for commercial exploitation.

Novel bioadhesive for wound closure in animals or humans

Universitat Politècnica de Catalunya - UPC posted this:

SELF DRIVEN MICROFLUIDIC FILTER FOR SEPERATING LIQUID FROM A LIQUID INCLUDING DEFORMABLE PARTICLES (I.E. PLASMA FROM BLOOD)This Novel Microfluidic circuit has been developed in MicroTechLab of the Mechanical Engineering Department of UPC. Currently, partners to further develop the system and/or to establish commercial agreements along with technical cooperation are sought.

SELF DRIVEN MICROFLUIDIC FILTER FOR SEPERATING LIQUID FROM A LIQUID INCLUDING DEFORMABLE PARTICLES (I.E. PLASMA FROM BLOOD)

Universitat Politècnica de Catalunya - UPC posted this:

A device for electromechanical stimulation of 2D monolayer and 3D stem cell’s cultures for tissue engineering applications New device and apparatus for mechanical or simultaneous electromechanical stem cell cultures have been designed and patented by UPC and IGTP. The device is disposable and allows sterile mechanical stimulation on standard Petri dishes without breaking the sterile barrier. Partners to further develop the system and/or to establish commercial agreements along with technical cooperation are sought.

A device for electromechanical stimulation of 2D monolayer and 3D stem cell’s cultures for tissue engineering applications

Universitat Politècnica de Catalunya - UPC posted this:

New inorganic cement for biomedical applications A novel magnesium phosphate cement with good properties for clinical applications has been patented and developed. It is envisaged as an excellent root canal filler for endodontic treatments, improving the commercial materials currently used for this application. Partners to establish commercial agreements along with technical cooperation are sought.

New inorganic cement for biomedical applications

Universitat Politècnica de Catalunya - UPC posted this:

New nanostructured material for tissue regeneration A new ion release system for revascularization and tissue regeneration based of calcium phosphate glass nanoparticles has been patented and developed. Partners to further develop the technology and/or to establish commercial agreements along with technical cooperation are sought.

New nanostructured material for tissue regeneration

Universitat Politècnica de Catalunya - UPC posted this:

New method to test tuberculosis virulence A new easy, fast and reliable method to determine the virulence of Mycobacterium tuberculosis (MTB) has been developed by a group of scientists from UPC and IGTP. Partners to further develop the technology and/or to establish comercial agreements along with technical cooperation are sought.

New method to test tuberculosis virulence

Universitat Politècnica de Catalunya - UPC posted this:

Environmental Quality Assessment of contaminated soils Environmental quality of soils is determined using analytical chemistry methods, with expensive and sophisticated equipment. Toxicity assays provide a global response regarding the danger of contaminated soil to living organisms. However bioassays are based in lengthy experimental procedures (between 7 and 28 days) to provide reliable results. Normalized soil assays use different species of earthworms and collembola that must be grown and maintained in specialized facilities. Partners to further develop the technology and/or to establish commercial agreements along with technical cooperation are sought.

Environmental Quality Assessment of contaminated soils

1
2
3
4
5